IOMAI CORPORATION IOMI (NASDAQ) $ 6.59 Change: +0.01 +0.15% | Volume: 18,000

IOMAI CORP - Fundamental Profile

Company Information

Ticker Symbol: IOMI
Exchange: NASD
Contact Info: 20 Firstfield Road Gaithersburg MD 20878 301-556-4500
CEO/President:
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: Iomai Corporation is pioneering the delivery to the skin of potent biological molecules for vaccination and immuno-modulation that will prevent or treat a broad range of diseases. Transcutaneous immunization, developed at Walter Reed Army Institute of Research, is licensed exclusively to Iomai Corporation. Transcutaneous immunization is its proprietary platform for the development of the next generation of vaccines that will replace the needle and syringe and, it believes that it will result in more effective prevention and treatment of disease.

Share Information

Shares Outstanding: 25,590 (000) Market Value: 167,940 ($000)
Percentage of Inst.Shareholders: 21.02% Number of Inst.Shareholders: N/A%
Last Quarter Sales: 1.84 ($Mil.) Last Quarter Net Income: -6.50 ($Mil.)
Last Quarter EPS: -0.25 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -1.00
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +41.90 64.08
GILEAD SCIENCES +37.60 53.21
AMYLIN PHARMA I -56.00 21.88
BIOGEN IDEC INC -12.60 51.33
GENENTECH INC +43.40 98.45